Firepower 2020

Update: 2020-02-19

Description

With dealmaking a cornerstone of the growth strategy, 2020 will be a robust year for life sciences M&A. To succeed, companies must continue to focus their business models, close near term growth gaps and invest in future innovation.

Comments

In Channel

How AI is supporting pharmaceutical manufacturing and supply chain

2024-06-1924:14

How the path to a sustainable health system unlocks value

2023-03-2932:24

How global events are shaping the pharmaceutical supply chain

2023-03-2623:54

How life sciences companies are measuring their ESG impact

2022-12-1926:02

How unlocking the power of data can fuel better health outcomes

2022-05-0822:33

How women are shaping the life sciences industry

2022-03-2229:58

How data can help redesign the health experience

2022-02-2116:52

How shorter clinical trial processes prolong the lives of patients

2021-10-2029:14

How digital solutions will help close the health equity gap

2021-08-1232:47

The Age of Health Experience

2021-08-1208:01

Five trends driving the emergence of personalized Health ecosystem

2020-06-0128:00

New Horizons: What connections will move health from reimagining to reality?

2020-04-1726:39

Firepower 2020

2020-02-1920:16

Pulse of the industry 2019

2019-11-0526:15

How can we make common ground the foundation for real change?

2019-10-1030:44

Unlocking the power of data to improve health outcomes: five trends to watch (Audiobook)

2019-05-0924:47

2019 EY M&A Firepower report (Audiobook)

2019-02-0621:16

When a human body is the biggest data platform, who will capture value? (Podcast: Pamela Spence/Jackie Hunter)

2019-01-1619:12

EY Pulse of the Industry 2018 (Audiobook)

2018-10-2224:28

EY Life Sciences 4.0 (Audiobook)

2018-07-1526:22

00:00

#box-pro-ellipsis-17640998527794{-webkit-line-clamp:2;}Firepower 2020

Firepower 2020

Firepower 2020